SMAD2 and pulmonary fibrosis: As reported in previous researches, the inhibition of Smad2/3 signaling pathway could significantly attenuate the formation of scar tissue in central nervous system and pulmonary fibrosis (Ahmed et al., 2014; Luo et al., 2014; Li et al., 2020).